Dr. Geliebter will speak on the interplay between microbiota, the immune system and genetics, as well as the complexities of current data on microbiota and pro- and prebiotics treatments. He received his Undergraduate Degree in Biology from the Hebrew University of Jerusalem and his PhD Degree in Microbiology and Immunology from State University of New York, Downstate Medical Center. His postdoctoral studies on the genetics of major histocompatibility complex were carried out in the laboratory of Dr. Stanley Nathenson at the Albert Einstein College of Medicine. Dr. Geliebter has held faculty positions at The Rockefeller University, The Albert Einstein College of Medicine and is currently a Professor in the Department of Pathology, Microbiology and Immunology and the Department of Otolaryngology at New York Medical College.
Dr. Geliebter’s Laboratory has been engaged in funded research and projects/programs include molecular pathogenesis and hormonal determinants of thyroid cancer and Traditional Chinese Medicine for the treatment of allergy/eczema. He has published over 90 peer-reviewed papers and numerous book chapters.